Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

被引:63
作者
Furst, D. E.
Breedveld, F. C.
Kalden, J. R.
Smolen, J. S.
Burmester, G. R.
Emery, P.
Keystone, E. C.
Schiff, M. H.
van Riel, P. L. C. M.
Weinblatt, M. E.
Weisman, M. H.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA
[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands
[3] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, D-8520 Erlangen, Germany
[4] Vienna Gen Hosp, Inst Rheumatol, Clin Internal Med 3, Vienna, Austria
[5] Charite Hosp, Dept Rheumatal & Clin Immunol, Berlin, Germany
[6] Univ Leeds, Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England
[7] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON M5G 1X5, Canada
[8] Denver Arthrit Clin, Denver, CO USA
[9] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[10] Brigham & Womens Hosp, Boston, MA 02115 USA
[11] Cedar Sinai Hosp, Los Angeles, CA USA
关键词
D O I
10.1136/ard.2006.061937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2 / 15
页数:14
相关论文
共 264 条
[41]  
Carter JD, 2005, J RHEUMATOL, V32, P1413
[42]   Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab [J].
Cauza, E ;
Spak, M ;
Cauza, K ;
Hanusch-Enserer, U ;
Dunky, A ;
Wagner, E .
RHEUMATOLOGY INTERNATIONAL, 2002, 22 (06) :227-232
[43]  
Cerenak A, 2004, J AM SOC BREW CHEM, V62, P1
[44]   Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].
Chaudhari, U ;
Romano, P ;
Mulcahy, LD ;
Dooley, LT ;
Baker, DG ;
Gottlieb, AB .
LANCET, 2001, 357 (9271) :1842-1847
[45]  
Chevalier X, 2005, J RHEUMATOL, V32, P1317
[46]  
Christopher L, 2002, ARTHRITIS RHEUM-US, V46, pS358
[47]   Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial [J].
Clair, EWS ;
van der Heijde, DMFM ;
Smolen, JS ;
Maini, RN ;
Bathon, JM ;
Emery, P ;
Keystone, E ;
Schiff, M ;
Kalden, JR ;
Wang, B ;
DeWoody, K ;
Weiss, R ;
Baker, D .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3432-3443
[48]   Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].
Clegg, DO ;
Reda, DJ ;
Mejias, E ;
Cannon, GW ;
Weisman, MH ;
Taylor, T ;
BudimanMak, E ;
Blackburn, WD ;
Vasey, FB ;
Mahowald, ML ;
Cush, JJ ;
Schumacher, HR ;
Silverman, SL ;
Alepa, FP ;
Luggen, ME ;
Cohen, MR ;
Makkena, R ;
Haakenson, CM ;
Ward, RH ;
Manaster, BJ ;
Anderson, RJ ;
Ward, JR ;
Henderson, WG .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020
[49]  
Cohen G, 2005, CLIN EXP RHEUMATOL, V23, P795
[50]   Etanercept treatment for autoimmune inner ear disease: Results of a pilot placebo-controlled study [J].
Cohen, S ;
Shoup, T ;
Weisman, MH ;
Harris, J .
OTOLOGY & NEUROTOLOGY, 2005, 26 (05) :903-907